Guinea vs Guinea-Bissau: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Guinea
2.8%
in 2024
Guinea-Bissau
2.7%
in 2024
Guinea rank
8th
Guinea-Bissau rank
9th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Guinea
- Guinea-Bissau
How they compare
Guinea currently reports 2.8% against 2.7% in Guinea-Bissau, a difference of 0.1%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Guinea-Bissau ahead.
Guinea ranks 8th and Guinea-Bissau ranks 9th of 246 countries.
Guinea-Bissau has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.7% | 2.8% | 0.1% | Guinea-Bissau |
| 2020s | 2.7% | 2.7% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Guinea or Guinea-Bissau?
- Guinea, at 2.8% against 2.7% in Guinea-Bissau as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Guinea and Guinea-Bissau?
- 0.1%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Guinea-Bissau?
- 10 years are reported by both, from 2015 to 2024.
- How do Guinea and Guinea-Bissau rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Guinea ranks 8th and Guinea-Bissau ranks 9th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.